Level Four Financial’s Charles River Laboratories CRL Stock Holding History

Level Four Financial’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$276K	Buy	+669	New	+$278K	0.12%	215

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Level Four Financial's CRL Position: Q3 2021 in Review

Level Four Financial opened a new position in Charles River Laboratories (CRL) in Q3 2021: 669 shares worth $276K. The stake represents 0.12% of the portfolio and ranks #215 among its holdings.

677 funds tracked by Wall St. Rank hold CRL as of Q3 2021.

Level Four Financial held 669 shares of Charles River Laboratories worth $276K as of Q3 2021.
Charles River Laboratories was a new Level Four Financial position in Q3 2021.
Charles River Laboratories made up 0.12% of Level Four Financial's portfolio in Q3 2021, its #215 holding.
677 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2021.

Based on Level Four Financial's 13F filing for Q3 2021, filed 12 Oct 2021.